INTRODUCTION {#sec1-1}
============

*Daśamūla* literally means 'ten-roots'. The 10 plant drugs of *Daśamūla* (DM) are grouped as *Bṛhatpañcamūla* (roots of five tree species) and *Laghupañcamūla* (roots of five shrubs or herbs). The *Bṛhatpañcamūla* are *Bilva*, *Agnimantha*, *Śyonāka*, *Pāṭalā*, and *Gaṃbhārī* while *Laghupañcamūla* include *Pṛṣṇiparṇī*, *Śālaparṇī*, *Bṛhatī*, *Kaṇṭakāri*, and *Gokṣura*. It is estimated that more than 10,000 M. tonnes of plant raw drugs belonging to DM group is being consumed every year by Indian herbal industry contributing to nearly \~Rs. 500 crore (\~USD 1 billion) turnover through the sale of herbal formulations containing this group of medicinal plants.\[[@ref1]\]

DM plants are the major ingredients of top-selling Ayurvedic products such as *Daśamūlarishta*, *Daśamūla Kaśāya*, and *Daśamūlakaṭutrayādi Kvāyam*. *Caraka* has mentioned the components of *Daśamūla* under the *śvayathuhara gạna* i.e. the group of 10 drugs that combat oedema\[[@ref2]\] and uses the word *Mahat Pañcamūla* and *Daśamūla* in several contexts. *Suśruta* gives a classification as *Bṛhatpañcamūla* and *Laghupañcamūla* in the classification of drugs.\[[@ref3]\] The Ayurvedic texts have mentioned that DM plant drugs mainly pacify *vāta dośa*.\[[@ref3]\] Currently, the official Ayurvedic Formularies of India (AFI) have listed the ingredients of DM, their Ayurvedic/Sanskrit names, and the correlated botanical sources.\[[@ref4][@ref5][@ref6]\]

Even though the exact methodology adopted to identify botanical sources for Ayurvedic drugs has not been published, it has been mentioned briefly by Bapalal Vaidya\[[@ref7]\] and Balwant Singh and Chunekar\[[@ref8]\] that it was done through etymological analysis of drug synonyms as given in classical texts and by interviewing traditional practitioners and Ayurvedic scholars. This required the active engagement of scholarship in Sanskrit, Ayurvedic practice, and plant taxonomy. Several scholars have correlated DM with different botanical entities including some regional variants or substitutes. It is important for the industry as well as researchers to be aware of both the authentic as well as other botanical entities used as equivalents, for two reasons. Firstly, to develop critical pharmacognostic standards to distinguish the former from the latter, for the purpose of quality control and secondly to study the legitimacy of such substitution, i.e. their equivalence in terms of the bioactivities. Proactively identifying legitimate substitutes for authentic but unavailable plant drugs is the need of the hour for the Ayurvedic industry and for that a proper awareness about variation in the usage of different botanical identities is the first step.

MATERIALS AND METHODS {#sec1-2}
=====================

In order to compile the information available on the botanical sources of *Daśamūla* group of plant drugs a detailed literature review was carried out on selected classical and current day texts on Ayurveda and trade of plant drugs as provided in [Table 1](#T1){ref-type="table"}, including the official Ayurvedic pharmacopoeias published by the Government of India. The basis of selection of these texts is that they are primary references on botanical nomenclature correlation work of Ayurvedic plants and not just a mere report on traded plants and botanical entities. The DM species and their substitutes as mentioned in AFIs have been summarized in [Table 2](#T2){ref-type="table"}. Information from other texts regarding the authentic plant sources, their substitutes and the parts used has been incorporated in [Table 3](#T3){ref-type="table"}. For the current study, the plant species mentioned in the official pharmacopoeias of Ayurveda have been considered as authentic and legitimate substitutes.

###### 

Ayurveda books referred for listing botanical entities correlated to *Daśamūla* species
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###### 

*Daśamūla* and substitutes according to Ayurvedic Formulary of India (AFI)
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###### 

Botanical correlation of *Daśamūla* candidates as described in various published Ayurveda correlation works
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NB: The period of original Ayurvedic manuscripts \[[Table 1](#T1){ref-type="table"}: No 7 and 8\] is provided in parenthesis as per the published work "The History of Ayurveda".\[[@ref9]\]

RESULTS AND DISCUSSION {#sec1-3}
======================

The literature analysis indicated that the botanical entities and parts correlated as DM varied between scholarly works \[Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}\]. Confusion has also crept in because some authors have treated taxonomic synonyms of the same plant species as different botanical entities while a few have clubbed different species as one. Many authors have merely correlated the DM herbs to botanical entities but not mentioned the part to be used \[[Table 3](#T3){ref-type="table"}\]. This may be because it is implied that *Daśamūla* refers to roots.

We have firstly discussed the findings on the botanical entities and substitutes as provided in three different editions of AFI \[[Table 2](#T2){ref-type="table"}\] and in other works \[[Table 3](#T3){ref-type="table"}\]. Subsequently we have also discussed the reports on the parts to be used.

Botanical entities correlated as DM and their substitutes as reported in different scholarly works {#sec2-1}
--------------------------------------------------------------------------------------------------

### Bilva, Śyonāka, and Gaṃbhārī {#sec3-1}

There is no controversy regarding the botanical correlation of *Bilva*, *Śyonāka*, and *Gaṃbhārī*. All scholars have correlated *Aegle marmelos* Corr. (Rutaceae) as the source of *Bilva*, *Oroxylum indicum* Vent. (Bignoniaceae) as *Śyonāka* and *Gmelina arborea* Linn. (Verbenaceae) as *Gaṃbhārī*. There is no mention of substitute plant source for *Bilva* by any of the authors \[Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}\]. Bapalal Vaidya has listed *Ailanthus excelsa* Roxb. as a substitute for *Śyonāka*.\[[@ref7]\] Kolammal mentions *Gmelina asiatica* Linn. as a substitute for *Gaṃbhārī*\[[@ref10]\] while *Trewia nudiflora* Linn. (Euphorbiaceae) has been provided as a substitute for *Gaṃbhārī* by Bapalal Vaidya\[[@ref7]\] Chunekar on the other hand has provided both *Premna flavescens* Ham. (Verbenaceae) as well as *Trewia nudiflora* Linn. as substitutes for *Gaṃbhārī*.\[[@ref11]\]

### Agnimantha {#sec3-2}

There is an inherent difference within the three AFIs published with regard to the botanical sources of *Agnimantha* \[[Table 2](#T2){ref-type="table"}\]. The first edition (Part I) mentions *Clerodendrum phlomidis* Linn.f as the authentic botanical source and *Premna integrifolia* Linn. as well as *Premna mucronata* Roxb. as substitutes.\[[@ref4]\] However, in the second edition of Part I, *Premna integrifolia* has been mentioned as the authentic plant source and *C. phlomidis* as well as *P. mucronata* are provided as the substitutes.\[[@ref5]\] In Part II of the first edition of AFI on the other hand, *C. phlomidis*. Linn.f. has been listed as the authentic *Agnimantha* and *Premna obtusifolia* R. Br as well as *Premna mucronata* Roxb. are listed as the substitutes \[[Table 2](#T2){ref-type="table"}\].\[[@ref6]\] The basis for this variation in listing of botanical sources for *Agnimantha* is not provided and hence not clear.

Several authors have correlated *Agnimantha* to *Clerodendrum phlomidis* Linn.f \[[Table 3](#T3){ref-type="table"}\]. Kolammal correlates *Agnimantha Premna serratifolia* Linn. and *Premna latifolia* Roxb. as substitute.\[10\] Warrier and Sivarajan correlate *Agnimantha* to *Premna corymbosa* Rottl.\[[@ref12][@ref13]\] The texts and lexicons of Ayurveda mention two varieties of *Agnimantha*, namely *Bṛhat Agnimantha* (big variety) and *Laghu Agnimantha* or *Kṣudra Agnimantha* (small variety) which have been correlated to *Premna integrifolia* and *Clerodendrum phlomidis* respectively by the scholars \[[Table 3](#T3){ref-type="table"}\].\[[@ref7][@ref11]\] Sharma (2006) mentions two varieties of Agnimantha as Agnimantha (bigger variety) correlated to Premna mucronata Roxb and Tarkārī (smaller variety) as *Clerodendrum phlomidis*.\[[@ref14]\] *Premna serratifolia* Linn. and *Premna spinosa* Roxb. are the other species correlated to *Agnimantha*. Both these botanical names are treated as synonyms of *Premna integrifolia* Linn. by plant taxonomists. *Premna latifolia* Roxb.Var. mucronata C.B. Clarke (a botanical synonym of *Premna mucronata* Roxb.) has also been considered by some authors as *Agnimantha*.\[[@ref8][@ref15][@ref16]\] According to Nadkarni, as well as Kamat and Mahajan *Clerodendrum inerme* (L.) Gaertn is a source of *Agnimantha*.\[[@ref17][@ref18]\]

No substitute species is mentioned for any of the 10 candidates of DM except for *Agnimantha* in AFI \[[Table 2](#T2){ref-type="table"}\].

### Pāṭalā {#sec3-3}

For example in the case of the plant drug *Pāṭalā*, *Stereospermum suaveolens* (L.f.) DC., and *Stereospermum chelonoides* (L.f.) DC of Bignoniaceae are botanical synonyms but have been mentioned as different species by Kamat and Mahajan\[17\] \[[Table 3](#T3){ref-type="table"}\]. Kolammal correlates *Stereospermum tetragonum* DC. (*Syn. Stereospermum chelonoides* C.B. Clarke) as *Pāṭalā*, and *Radermachera xylocarpa* (Syn. *Stereospermum xylocarpum* Benth and Hook) as another kind of *Pāṭalā* called *Ghaṇṭāpāṭalā* or *Kāṣṭhapāṭalā*,\[10\] Warrier correlates *Stereospermum colais* (Dillwyn) Mabb as *Pāṭalā*.\[[@ref19]\] *Stereospermum chelonoides* has been considered as *Kāṣṭhapāṭalā* by Kamat and Mahajan.\[[@ref17]\] Similarly some entities that are not synonymous have been clubbed together as synonymous e.g. *Stereospermum chelonoides* and *Stereospermum colais* (Dillwyn) Mabb are distinct species but have not been distinguished by Sastry\[[@ref20]\] \[[Table 3](#T3){ref-type="table"}\]. *Stereospermum tetragonum* DC. which is actually a botanical synonym of *Stereospermum colais* (Dillwyn) Mabb, has been listed as another source of *Pāṭalā,*.\[[@ref21]\]

### Bṛhatī and Kaṇṭakāri {#sec3-4}

*Bṛhatī* and *Kaṇṭakāri*, are referred as *Bṛhatī Dvaya*. They have similar properties as per Ayurveda in terms of *Rasa* (taste) and *Guṇa* (properties) and textual references indicate that they are used together.\[[@ref20]\] AFI correlates *Bṛhatī* to *Solanum indicum* Linn. (syn. *Solanum anguivi* Lam.) and *Kaṇṭakāri*, to *Solanum xanthocarpum* Schard and Wendle (syn. *Solanum virginianum* L.), both of Solanaceae. Most of the scholars have agreed with this correlation as can be seen in [Table 3](#T3){ref-type="table"}. However, a few scholars from southern India have included *Solanum melongena* Linn. also as the source of *Bṛhatī* \[[Table 3](#T3){ref-type="table"}\].\[[@ref13]\] Eventhough AFI mentions no substitutes for *Bṛhatī* and *Kaṇṭakāri*, Sharma (2006) and Singh (1999) have said *Solanum incanum* Linn., *Solanum torvum* Swartz., and *Solanum melongena* Linn. as substitutes.\[[@ref8][@ref14]\]

### Śālaparṇī and Pṛṣṇiparṇī {#sec3-5}

The text of *Caraka* mentions *Catasra Parṇī* which includes *Śālaparṇī* and *Pṛṣṇiparṇī*,\[[@ref22]\] They are used together and one is also used in the place of the other in some parts of the country. Both are different plant species belonging to the same family (Fabaceae) as correlated in the API. The controversy regarding *Pṛṣṇiparṇī*, and *Śālaparṇī*, is region based. *Uraria picta* Desv. is the authentic plant source of *Pṛṣṇiparṇī*, as per API, but *U. lagopodioides* DC. is also being used by the industry due to unavailability of *U. picta* in the required volumes.\[[@ref1]\] However, AFI recognizes no substitute for *Pṛṣṇiparṇī*.\[[@ref4][@ref5][@ref6]\] In Kerala, *Desmodium gangeticum* (L.) DC., which is known as *Śālaparṇī*, in API, is used as *Pṛṣṇiparṇī*, while *Pseudrathria viscida* is used as *Śālaparṇī*.\[[@ref13]\] According to Warrier *Pseudrathria viscida* is *Śālaparṇī*, and *Desmodium gangeticum* is *Pṛṣṇiparṇī*,\[[@ref12][@ref23]\] So, in all, there are at least four candidates, namely *U. picta* Desv., *U. lagopodioides* DC., *D. gangeticum* (L.) DC., and *P. viscida* Wight and Arn that are in use as *Pṛṣṇiparṇī*.

### Gokṣura {#sec3-6}

*Gokṣura* is correlated to *Tribulus terrestris* Linn. by all the scholars. *Pedalium murex* Linn. is considered as *Bṛhatī Gokṣura* (bigger variety) by some authors.\[[@ref8][@ref11][@ref12][@ref14][@ref20]\] Bapalal Vaidya considers *Pedalium murex* Linn., *Xanthium strumarium* L., and *Martynia daindra* Glox. are the other species used as *Gokṣura*.\[[@ref7]\]

### Plant parts reported for Daśamūla {#sec3-7}

The main observation from [Table 2](#T2){ref-type="table"} is that there is a variation in the listing of plant parts used between the Part I (editions I and II) and Part II of AFI. In the first edition, only roots are listed as plant drugs for all the 10 plant entities constituting DM group.\[[@ref4]\] In the second edition of Part I, stem bark for *Bṛhatī pañcamūla* and whole plant for *Laghu pañcamūla* have been listed in addition to the roots, under the formulations containing DM, such as *Daśamūlāriṣṭam*, *Daśamūlaharītakī Leha*, and *Daśamūla Kvātha Cūrnam*.\[[@ref5]\] Part II of AFI reverts to roots being the only plant part to be used, under the formulations of *Bṛhacchagalyādya ghṛtam* and *Daśamūla Taila*.\[[@ref6]\] Thus, the use of stem bark has been mentioned as substitute for roots of *Bṛhatī pañcamūla* and whole plant as substitute for the *Laghu pañcamūla* only in the second edition of AFI Part I\[[@ref5]\] and not in AFI Part I edition I nor in AFI Part II.\[[@ref4][@ref6]\]

The Ayurvedic Pharmacopeias of India (API) dealing with single ingredients have mentioned roots of *Bṛhatī pañcamūla* and whole plant of *Laghu pañcamūla* as the plant parts to be used for DM.\[[@ref24][@ref25][@ref26][@ref27]\] On the other hand the API on formulations lists the roots or stem bark of *Bṛhatī pañcamūla* and whole plant of *Laghu pañcamūla* as parts to be used.\[[@ref28][@ref29]\] API (formulations) in the context of *Daśamūla ghṛta* has considered has *Premna integrifolia* as official substitute for *Clerodendrum phlomidis* and considered stem bark and whole plant as the parts used.\[[@ref28]\] In the context of *Daśamūlaharītakī Leha* root/stem bark and whole plant of the drugs has been taken into consideration.\[[@ref29]\]

The main question in this regard is that the basis of why stem bark or whole plants have been listed as substitutes for roots is not clear or elaborated in the AFI or API.

Classical Ayurveda texts around 16^th^ century AD such as *Yogaratnākara* have indicated the use of substitute drugs (*Pratinidhi Dravya*) in the absence of original drugs (*Abhāva Dravya*) e.g., *Musta* (Cyperus rotundus) has been suggested as a substitute for *Ativiśa* (*Aconitum heterophyllum*).\[[@ref30][@ref31]\]

A few references can also be found regarding substituting with alternative parts of the same plant when the intended parts are not practical to be harvested. For e.g., when flowers of *Bilva* (Aegle marmelos) are unavailable, use of unripe fruits has been suggested in *Bhaiṣajya Ratnāvalī* (*"Puṣhpābhāve phalaňchāmam viḍbhede bilwatah phalam*).\[[@ref32]\] There is mention about the use of *Śālaparṇī*, (*Desmodium gangeticum*) when *Pṛṣṇiparṇī* (*Uraria picta*) is unavailable.\[[@ref33]\] However, such references are few and far between, the logic is still not clear and it cannot be extrapolated as a thumb rule to all species. It requires further scientific exploration.

Future research needs to focus on not only identifying substitute species but also substitute parts that may be more available, for e.g., stem instead of roots or leaves instead of flowers, etc.

While roots are generally the part used in DM, there are a few authors who refer to other parts as well. Sastry mentions root bark as part to be used for both *Śyonāka* and *Pāṭalā* \[[Table 3](#T3){ref-type="table"}\].\[[@ref20]\]

Use of both root and whole plant for *Pṛṣṇiparṇī* and whole plant of *Bṛhatī*, *Kaṇṭakāri*, and *Gokṣura* has been mentioned by Bapalal Vaidya in *Ādarsha Niganṭu*.\[[@ref21]\] Other than AFI, scholars have not listed stem bark or whole plant as substitutes for roots \[[Table 3](#T3){ref-type="table"}\]. AFI does not provide the logic as to how stem bark or whole plant as substitutes.

Our work, has, for the first time compiled and analyzed the botanical entities that have been correlated in published texts as sources of one or more of DM group of raw drugs. This has brought to light the fact that there are several species reported as DM candidates other than the ones correlated in the official AFI. Over and above these, it is also an accepted fact that the Ayurvedic industries use several more species as sources of DM raw drugs depending on the geographical region and availability of herbs. There are also issues of authentic correlation of botanical entities, legitimacy of substitution, and controversies regarding parts used as well as taxonomic synonymy that need to be resolved.\[[@ref34][@ref35]\] These can only be resolved through systematic etymological analysis of Ayurvedic terms for each of the *Daśamūla* candidates and correlation to the accurate botanical entity with the help of competent field botanists, Sanskrit, and Ayurvedic scholars. Such studies need to be published in peer reviewed journals and provided also in the official pharmacopoeias for future reference so that the basis of correlation is clear. It is also important to research and publish the pharmacognostic standards and the comparative bioactivity of original herbs (and parts) alongside substitutes (and parts), so that the sector knows about the legitimacy of substitution.

CONCLUSIONS {#sec1-4}
===========

Through a literature analysis of several scholarly works, this article has brought out a list of botanical sources correlated as DM plants. It is clear from the list that there is quite a bit of confusion in terms of the right botanical entity, plant part or substitutes used. It has brought to light issues that need to be resolved in terms of authenticity of correlation of Ayurvedic entities to botanical sources like *Pṛṣṇiparṇī*, *Śālaparëī*, and *Agnimantha*. The need to spell out the logic behind use of substitute parts and species has also been highlighted. Such a list is made available as one publication for the first time. It will be useful for any further work on DM, be it for confirmation of botanical source or for pharmacognostic and pharmacological studies to establish quality standards or legitimacy of substitution. Since DM is a very important plant drug group for the Ayurvedic industry, further Research and Development in the above areas is warranted.
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